Therefore, the aims of this study are to define the optimal cut-off values for IL-6 and CRP, and to investigate the diagnostic performance of these biomarkers both in combination and alone for the early diagnosis of neonatal sepsis using large number of culture-proven sepsis, clinical sepsis, and controls. The gene discussed is IL6; the disease is Sepsis.